JP2019529566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529566A5 JP2019529566A5 JP2019538108A JP2019538108A JP2019529566A5 JP 2019529566 A5 JP2019529566 A5 JP 2019529566A5 JP 2019538108 A JP2019538108 A JP 2019538108A JP 2019538108 A JP2019538108 A JP 2019538108A JP 2019529566 A5 JP2019529566 A5 JP 2019529566A5
- Authority
- JP
- Japan
- Prior art keywords
- ubenimex
- administered
- medicament
- inhibitor
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662400963P | 2016-09-28 | 2016-09-28 | |
| US62/400,963 | 2016-09-28 | ||
| US201762460606P | 2017-02-17 | 2017-02-17 | |
| US62/460,606 | 2017-02-17 | ||
| US201762469722P | 2017-03-10 | 2017-03-10 | |
| US62/469,722 | 2017-03-10 | ||
| PCT/US2017/054087 WO2018064373A1 (en) | 2016-09-28 | 2017-09-28 | Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529566A JP2019529566A (ja) | 2019-10-17 |
| JP2019529566A5 true JP2019529566A5 (https=) | 2020-07-02 |
| JP7022136B2 JP7022136B2 (ja) | 2022-02-17 |
Family
ID=61760848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538108A Expired - Fee Related JP7022136B2 (ja) | 2016-09-28 | 2017-09-28 | 非アルコール性脂肪性肝炎の治療のための方法及び医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10588880B2 (https=) |
| EP (1) | EP3518918A4 (https=) |
| JP (1) | JP7022136B2 (https=) |
| KR (1) | KR102399254B1 (https=) |
| CN (1) | CN109862888B (https=) |
| WO (1) | WO2018064373A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102399254B1 (ko) | 2016-09-28 | 2022-05-17 | 아이거 바이오파마슈티컬스 인코포레이티드 | 비-알코올성 지방간염의 치료를 위한 방법 및 약제학적 조성물 |
| US20210369693A1 (en) * | 2017-11-28 | 2021-12-02 | Eiger Biopharmaceuticals, Inc. | Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis |
| WO2019209738A1 (en) * | 2018-04-24 | 2019-10-31 | Ph Pharma Co., Ltd. | Use of neutrophil elastase inhibitors in liver disease |
| EP3811937A1 (en) * | 2019-10-24 | 2021-04-28 | Sorbonne Universite | Compounds for use in the prevention and/or treatment of non-alcoholic fatty liver disease |
| US11478533B2 (en) | 2020-04-27 | 2022-10-25 | Novo Nordisk A/S | Semaglutide for use in medicine |
| AU2022376563A1 (en) | 2021-11-01 | 2023-12-07 | Alkahest, Inc. | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4029547A (en) | 1974-07-01 | 1977-06-14 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Biologically active substance, bestatin, and production thereof |
| US4052449A (en) | 1974-07-01 | 1977-10-04 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Biologically active substance, bestatin, and production thereof |
| JPH0759507B2 (ja) * | 1989-02-23 | 1995-06-28 | 日本化薬株式会社 | 骨髄異形成症候群治療剤 |
| CN1098249C (zh) * | 1995-06-21 | 2003-01-08 | 国家医药管理局四川抗菌素工业研究所 | 乌比美克及含乌比美克的药物组合物治疗病毒性肝炎的用途 |
| WO2005000227A2 (en) | 2003-06-06 | 2005-01-06 | Intermune, Inc. | Methods of treating tnf-mediated disorders |
| NZ570381A (en) * | 2006-02-09 | 2011-02-25 | Daiichi Sankyo Co Ltd | Anti-cancer pharmaceutical composition |
| JP2009109426A (ja) * | 2007-10-31 | 2009-05-21 | Sysmex Corp | 検体前処理液、ウイルス測定用キット及びウイルス検出方法 |
| US9072732B2 (en) * | 2010-11-22 | 2015-07-07 | The Regents Of The University Of California | Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver disease |
| US8962687B2 (en) * | 2012-12-05 | 2015-02-24 | Medicinova, Inc. | Method of treating liver disorders |
| WO2013142369A1 (en) | 2012-03-23 | 2013-09-26 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of pulmonary hypertension with leukotriene inhibitors |
| CA2819967C (en) | 2012-08-31 | 2016-03-22 | Intermune, Inc. | Use of pirfenidone concomitantly with ciprofloxacin |
| WO2014106846A2 (en) * | 2013-01-03 | 2014-07-10 | Oramed Ltd. | Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereof |
| SI3043865T1 (sl) * | 2013-09-11 | 2021-04-30 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Metode in farmacevtski sestavki za zdravljenje virusne okužbe s hepatitisom B |
| US20150111878A1 (en) * | 2013-10-22 | 2015-04-23 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
| HUE045209T2 (hu) * | 2013-12-04 | 2019-12-30 | Galmed Res & Development Ltd | Aramchol-sók |
| WO2016149126A1 (en) | 2015-03-13 | 2016-09-22 | The Board Of Trustees Of The Leland Stanford Junior University | Ltb4 inhibition to prevent and treat human lymphedema |
| CN104784178B (zh) * | 2015-05-08 | 2017-04-12 | 重庆医科大学 | 尼克酰胺作为有效成分在制备乙型肝炎治疗药物中的用途 |
| CN104887655A (zh) * | 2015-06-12 | 2015-09-09 | 上海来益生物药物研究开发中心有限责任公司 | 乌苯美司在制备用于预防和治疗炎症疾病和与炎症相关的感染疾病的药物制剂中的应用 |
| HK1257929A1 (zh) | 2015-11-06 | 2019-11-01 | Gemphire Therapeutics Inc. | 治疗混合性血脂异常 |
| KR102399254B1 (ko) | 2016-09-28 | 2022-05-17 | 아이거 바이오파마슈티컬스 인코포레이티드 | 비-알코올성 지방간염의 치료를 위한 방법 및 약제학적 조성물 |
| US20210369693A1 (en) | 2017-11-28 | 2021-12-02 | Eiger Biopharmaceuticals, Inc. | Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis |
-
2017
- 2017-09-28 KR KR1020197011062A patent/KR102399254B1/ko not_active Expired - Fee Related
- 2017-09-28 EP EP17857443.0A patent/EP3518918A4/en not_active Withdrawn
- 2017-09-28 US US16/335,662 patent/US10588880B2/en active Active
- 2017-09-28 WO PCT/US2017/054087 patent/WO2018064373A1/en not_active Ceased
- 2017-09-28 CN CN201780065451.5A patent/CN109862888B/zh active Active
- 2017-09-28 JP JP2019538108A patent/JP7022136B2/ja not_active Expired - Fee Related
-
2020
- 2020-02-04 US US16/781,971 patent/US11571403B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019529566A5 (https=) | ||
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| ES2767084T3 (es) | Nuevo uso | |
| JP2018514534A5 (https=) | ||
| CA2568443A1 (en) | Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihistamines | |
| HRP20160189T1 (hr) | Liječenje crohnove bolesti lakvinimodom | |
| JP2015038135A5 (https=) | ||
| EP2797584B1 (en) | Combinations of diacerein and non-steroidal inflammation drugs | |
| HRP20150644T1 (hr) | Metoda za lijeäśenje atrijalne fibrilacije | |
| CA2956257A1 (en) | Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals | |
| RU2008121767A (ru) | Пероральная фармацевтическая лекарственная форма, содержащая в качестве активных ингредиентов ингибитор протонного насоса совместно с ацетилсалициловой кислотой | |
| US7303761B2 (en) | Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin | |
| HRP20211826T1 (hr) | Čvrste farmaceutske kompozicije koje sadrže inhibitor integraze | |
| BG102669A (bg) | Метод за лечение и фармацевтичен състав | |
| JP2008533127A5 (https=) | ||
| JP2024533756A5 (https=) | ||
| Kaur et al. | Diacerein, its beneficial impact on chondrocytes and notable new clinical applications | |
| IL274414B1 (en) | Oral rifamycin sv compositions | |
| JP2019218379A5 (https=) | ||
| EA015304B1 (ru) | Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением | |
| JP2021504479A5 (https=) | ||
| CN100502870C (zh) | 含有瑞舒伐他汀或匹伐他汀和b族维生素的药物组合物 | |
| AR068560A1 (es) | Composiciones farmaceuticas que comprenden la combinacion de un agente antiinflamatorio no esteroide y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota artritis gotosa y enfermedades relacionadas | |
| RU2020121222A (ru) | Агонисты fxr для лечения заболеваний печени | |
| US11648240B2 (en) | Pharmaceutical composition comprising famotidine, lidocaine and melatonin |